Société GENFIT Euronext Paris
Actions
FR0004163111
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
||
3,428 EUR | 0,00% |
Métier
La société est installée à Lille, Paris, Zurich et Cambridge, MA (USA).
Ventes par activité
EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Research and Development of Innovative Medicines and Diagnostic Solutions
100,0
%
| 20 | 100,0 % | 29 | 100,0 % | +41,45% |
Ventes par région
EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
France
100,0
%
| 20 | 100,0 % | 29 | 100,0 % | +41,45% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 56 | 01/05/18 |
Founder | 68 | 01/09/99 | |
Thomas Baetz
DFI | Director of Finance/CFO | 50 | 22/04/21 |
John Brozek
CTO | Chief Tech/Sci/R&D Officer | 47 | - |
Stefanie Magner
CMP | Compliance Officer | 43 | 01/01/16 |
Pascal Caisey
COO | Chief Operating Officer | 56 | 01/09/19 |
Carol L. Addy
CTO | Chief Tech/Sci/R&D Officer | 64 | 09/09/19 |
Meriam Kabbaj
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/12/22 |
Dean Hum
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/01/00 |
Investor Relations Contact | 47 | 01/01/15 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 67 | 04/03/21 | |
Founder | 68 | 01/09/99 | |
Founder | 52 | 15/09/99 | |
Director/Board Member | 82 | 18/10/06 | |
Catherine Larue
BRD | Director/Board Member | 68 | 16/06/17 |
Director/Board Member | 56 | 16/06/17 | |
Katherine Kalin
BRD | Director/Board Member | 61 | 07/07/20 |
Eric Baclet
BRD | Director/Board Member | 64 | 07/07/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 49 834 983 | 43 212 891 ( 86,71 %) | 0 | 86,71 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+17,96% | 44,96 Md | |
+1,17% | 42,65 Md | |
+46,56% | 41,85 Md | |
-4,27% | 29,04 Md | |
+11,42% | 26,08 Md | |
-21,39% | 19,03 Md | |
+4,86% | 12,75 Md | |
+27,29% | 12,06 Md | |
-3,50% | 11,75 Md |
- Bourse
- Actions
- Action GNFT
- Action
- Société GENFIT